Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi today reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with its new next-generation COVID-19 booster vaccine candidate modelled on the Beta variant antigen and including GSK’s pandemic adjuvant. In the Phase 3 VAT02 Cohort 2 study, the Sanofi-GSK next-generation vaccine candidate ...
Two Stellenbosch University scientists have been selected for TIME magazine's list of 100 most influential people of 2022.
/PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and...
Monoclonal antibodies and their potential role in combatting COVID-19 - IAVI. Numerous monoclonal antibodies are already in development for both treatment and p
40 years of AIDS vaccine research - IAVI. A timeline of major milestones in the decades-long effort to develop an HIV vaccine.